The company is analysing clinical, genomic and proteomic data to classify cancer patients into treatment "buckets" based on how they respond to therapies, with the aim of helping clinicians make more informed treatment decisions.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/WGAo1kO
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment